Metabolomics Market Challenges, Drivers, and Forecast by 2031

Historic Data: 2021-2023   |   Base Year: 2024   |   Forecast Period: 2025-2031

Coverage: Metabolomics Market covers analysis By Products and Services (Metabolomics Instruments, Metabolomics Tools and Services) ; Applications (Drug Discovery, Toxicity Testing, Disease Diagnosis, Personalized Medicines, Others), and Geography (North America, Europe, Asia Pacific, and South and Central America)

  • Report Date : Aug 2025
  • Report Code : TIPRE00008670
  • Category : Life Sciences
  • Status : Upcoming
  • Available Report Formats : pdf-format excel-format
  • No. of Pages : 150

The Metabolomics Market is expected to register a CAGR of 13.2% from 2025 to 2031, with a market size expanding from US$ XX million in 2024 to US$ XX Million by 2031.

The report is segmented by Products and Services (Metabolomics Instruments, Metabolomics Tools and Services); and Applications (Drug Discovery, Toxicity Testing, Disease Diagnosis, Personalized Medicines, Others). The global analysis is further broken down at the regional level and major countries. The report offers the value in US$ for the above analysis and segments.

Purpose of the Report

The report Metabolomics Market by The Insight Partners aims to describe the present landscape and future growth, top driving factors, challenges, and opportunities. This will provide insights to various business stakeholders, such as:

  • Technology Providers/Manufacturers: To understand the evolving market dynamics and know the potential growth opportunities, enabling them to make informed strategic decisions.
  • Investors: To conduct a comprehensive trend analysis regarding the market growth rate, market financial projections, and opportunities that exist across the value chain.
  • Regulatory bodies: To regulate policies and police activities in the market with the aim of minimizing abuse, preserving investor trust and confidence, and upholding the integrity and stability of the market.

Metabolomics Market Segmentation

Products and Services

  • Metabolomics Instruments
  • Metabolomics Tools and Services

Applications

  • Drug Discovery
  • Toxicity Testing
  • Disease Diagnosis
  • Personalized Medicines

Customize This Report To Suit Your Requirement

You will get customization on any report - free of charge - including parts of this report, or country-level analysis, Excel Data pack, as well as avail great offers and discounts for start-ups & universities

Metabolomics Market: Strategic Insights

metabolomics-market
  • Get Top Key Market Trends of this report.
    This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.

Metabolomics Market Growth Drivers

  • Increasing Prevalence of Chronic Diseases: More people get diagnosed with diabetes and cardiovascular problems and also become obese which makes the Metabolomics Market grow stronger. Through metabolomics, researchers study how diseases affect biochemical pathways in biological systems. Predictions show that medical laboratories need more metabolic testing because chronic diseases keep growing worldwide. Metabolomics finds new disease markers to detect conditions early tracks how conditions develop and tests how treatments work. The push for precision medicine leads healthcare providers to use metabolomics tools because these technologies reveal how each patient's metabolism differs from others. Healthcare systems worldwide are investing more in chronic disease management which will boost metabolomics market growth. The market share of companies delivering advanced metabolomics solutions will rise as they drive the entire industry's growth. The integration of metabolomics in clinical settings to improve diagnosis and treatment options is anticipated to fuel the expansion of this market in the coming years.
  • Advancements in Analytical Technologies: The Metabolomics Market grows due to advanced analytical tools including mass spectrometry (MS) and nuclear magnetic resonance (NMR) spectroscopy. New analytical tools help scientists analyze more samples faster while finding exact metabolite details. The market expansion of metabolomics will continue because future technology developments will help researchers and doctors do better metabolic tests. Mass spectrometry has become essential to metabolomics studies because it helps researchers find metabolites in complicated biological samples. The new technology makes data collection faster while increasing sensor precision which helps doctors find diseases and develop treatments using metabolic information. The market size for metabolomics will keep growing thanks to better and cheaper analytical tools which will boost companies that offer these technologies. The increasing adoption of these advanced techniques in clinical and research laboratories will further fuel the growth of the metabolomics market.
  • Growing Demand for Early Disease Detection and Diagnosis: The Metabolomics Market is expanding due to healthcare needs for fast disease detection and diagnosis. Identifying diseases early in cancer, heart disease, and brain conditions helps patients get better care and spend less money on healthcare. Metabolomics helps doctors find small metabolic changes that show when diseases start so they can diagnose problems earlier when treatment works best. Research shows that worldwide efforts to detect diseases early will make metabolomics testing more popular in healthcare. Scientists use body fluid metabolic data to find disease-specific or disease-stage biomarkers that help doctors make better diagnoses. The healthcare industry will expand metabolomics markets when it starts treating diseases earlier. As more healthcare providers use metabolomics tools for early disease detection the market will expand and diagnostic companies will gain more market share.

Metabolomics Market Future Trends

  • Expanding Applications in Drug Discovery and Development: The Metabolomics Market will grow more because scientists are using metabolomics methods to find new drugs in research and development. Research shows pharmaceutical companies will use metabolomics more often to find better drug markers that show how well drugs work and how harmful they are. Metabolomics helps scientists study how drugs work in the body so they can find side effects sooner during drug development. Pharmaceutical companies depend on metabolomics to find new drug response biomarkers for personalized medicine development. The new treatments will focus better on helping patients get better results. The pharmaceutical industry will demand more metabolomics tools because drug developers use these tools throughout preclinical and clinical testing stages. Companies that offer drug discovery solutions using metabolomics data will grow their market presence as demand for these services increases. Companies in the metabolomics market find a major growth prospect through their work in drug development and discovery.
  • Advancements in Non-Invasive Metabolomics Testing: New methods for measuring metabolites without needles will drive growth in the Metabolomics Market. Medical professionals now use simple tests on body samples like urine and blood to find metabolic changes without taking tissue samples. Research shows that clinical and research facilities will use non-invasive metabolomics tests more often because these tests return results faster with lower risks and better patient satisfaction. The market size for metabolomics tests will grow because they can now be performed with simple biological samples which makes them more appealing for healthcare professionals and patients to use. Doctors can easily include these simple tests in regular patient checkups to make metabolomics diagnosis more available. Companie The market will see more growth because companies are creating better non-invasive tools for precise metabolomics testing.
  • Increasing Collaboration between Academia and Industry: The future Metabolomics Market will see more academic institutions and business partners jointly working together. Research organizations and companies team up to speed up metabolomics science benefits for patient care and medical breakthroughs. Academic research will lead metabolomics innovation through new biomarker discoveries and advanced metabolic profiling methods according to future predictions. Private sector companies including pharmaceutical makers and diagnostic firms support the transformation of academic research into real-world products. Companies that partner with each other in this field will develop better metabolomics technology which increases market size and strengthens their market position. The partnership between academic researchers and industry professionals drives new healthcare solutions and drug development progress which increases market growth for metabolomics.

Metabolomics Market Opportunities

  • Rise of Metabolomics in Agricultural and Food Industries: The agricultural and food industries see metabolomics as a major market expansion area. Metabolomics helps farmers produce more crops while making better food and finding better farming methods that last. As predictions show more people want organic and modified crops the use of metabolomics will help create stronger and healthier plants for farming. Companies use metabolomics tests to find harmful substances in food products because this technology helps reveal what is present in food samples. The food industry uses metabolomics to track nutrition in food products and improve processing methods. As new uses emerge for metabolomics the market grows bigger for agricultural and food applications. Companies that offer metabolomics solutions for agriculture and food will claim more of the market space which helps the metabolomics market grow.
  • Increasing Demand for Metabolomics in Companion Diagnostics: The Metabolomics Market has better growth potential because more people are using companion diagnostic tests. Doctors use companion diagnostics to match medical treatments with patients based on their specific genetic and metabolic information. Personalized medical treatments drive up demand for metabolomics-based companion diagnostic tests. Metabolomics will help doctors find treatment responses that work best for each patient, especially in cancer care where personalized medicine is standard now. The market size of metabolomics technologies in companion diagnostics keeps expanding because of this trend. Metabolic profiling companion diagnostic tests will help healthcare providers treat patients better which will expand the market share of companies developing these tests. Metabolomics companies will benefit greatly from the companion diagnostics trend since precision healthcare keeps expanding in demand.
  • Biomarker Discovery and Drug Development: Most opportunities in the Metabolomics Market belong to biomarker research and medication development. The pharmaceutical industry uses metabolomics more often now to search for new biomarkers that will show how diseases progress and react to treatments because they develop drugs based on specific targets. Our study projects ongoing use of metabolomics tools during drug discovery especially in cancer, heart, and brain research fields. Biomarkers that measure drug performance and safety help developers save time and money during drug creation. Companies that specialize in metabolomics research for drug development will receive more business from customers who need better treatments and personalized solutions. The pharmaceutical industry will invest more in metabolomics solutions because drug companies will buy more services from companies that develop these technologies to find new biomarkers. Companies in the metabolomics market will have a strong potential for expansion due to this trend.

Metabolomics Market Regional Insights

The regional trends and factors influencing the Metabolomics Market throughout the forecast period have been thoroughly explained by the analysts at Insight Partners. This section also discusses Metabolomics Market segments and geography across North America, Europe, Asia Pacific, Middle East and Africa, and South and Central America.

metabolomics-market-global-geography
  • Get the Regional Specific Data for Metabolomics Market

Metabolomics Market Report Scope

Report Attribute Details
Market size in 2024 US$ XX million
Market Size by 2031 US$ XX Million
Global CAGR (2025 - 2031) 13.2%
Historical Data 2021-2023
Forecast period 2025-2031
Segments Covered By Products and Services
  • Metabolomics Instruments
  • Metabolomics Tools and Services
By Applications
  • Drug Discovery
  • Toxicity Testing
  • Disease Diagnosis
  • Personalized Medicines
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • Thermo Fisher Scientific Inc.
  • Waters Corporation, 
  • Agilent Technologies, Inc.
  • Human Metabolome Technologies, Inc.
  • Bruker Corporation
  • Shimadzu Corporation
  • PerkinElmer, 
  • Metabolon, Inc.
  • Leco Corporation
  • Hitachi High-Technologies Corporation

  • Metabolomics Market Players Density: Understanding Its Impact on Business Dynamics

    The Metabolomics Market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.

    Market players density refers to the distribution of firms or companies operating within a particular market or industry. It indicates how many competitors (market players) are present in a given market space relative to its size or total market value.

    Major Companies operating in the Metabolomics Market are:

    1. Thermo Fisher Scientific Inc.
    2. Waters Corporation, 
    3. Agilent Technologies, Inc.
    4. Human Metabolome Technologies, Inc.
    5. Bruker Corporation
    6. Shimadzu Corporation

    Disclaimer: The companies listed above are not ranked in any particular order.


    metabolomics-market-cagr

    • Get the Metabolomics Market top key players overview

    Key Selling Points

    • Comprehensive Coverage: The report comprehensively covers the analysis of products, services, types, and end users of the Metabolomics Market, providing a holistic landscape.
    • Expert Analysis: The report is compiled based on the in-depth understanding of industry experts and analysts.
    • Up-to-date Information: The report assures business relevance due to its coverage of recent information and data trends.
    • Customization Options: This report can be customized to cater to specific client requirements and suit the business strategies aptly.

    The research report on the Metabolomics Market can, therefore, help spearhead the trail of decoding and understanding the industry scenario and growth prospects. Although there can be a few valid concerns, the overall benefits of this report tend to outweigh the disadvantages.


    Frequently Asked Questions

    What is the expected CAGR of the Metabolomics Market?

    The Metabolomics Market is estimated to witness a CAGR of 13.2% from 2025 to 2031

    What are the driving factors impacting the Metabolomics Market?

    The major factors driving the Metabolomics Market are Increasing Prevalence of Chronic Diseases, Advancements in Analytical Technologies, and Growing Demand for Early Disease Detection and Diagnosis.

    What are the future trends of the Metabolomics Market?

    Future trends in the Metabolomics Market are Expanding Applications in Drug Discovery and Development, Advancements in Non-Invasive Metabolomics Testing, and Increasing Collaboration between Academia and Industry.

    Which are the leading players in the Metabolomics Market?

    Some of the players operating in the market are Thermo Fisher Scientific Inc., Waters Corporation, Agilent Technologies, Inc., Human Metabolome Technologies, Inc., Bruker Corporation, Shimadzu Corporation, PerkinElmer, Metabolon, Inc., Leco Corporation, Hitachi High-Technologies Corporation, and GL Sciences.

    What are the deliverable formats of the Metabolomics market report?

    The report can be delivered in PDF/PPT format; we can also share an excel datasheet based on the request.

    What are the options available for the customization of this report?

    Some customization options available based on the request are an additional 3–5 company profiles and a country-specific analysis of 3–5 countries of your choice. Customizations are to be requested/discussed before making final order confirmation# as our team would review the same and check the feasibility.

    Mrinal Kerhalkar
    Mrinal Kerhalkar
    Manager,
    Market Research & Consulting

    Mrinal is a seasoned research analyst with over 8 years of experience in Life Sciences Market Intelligence and Consulting. With a strategic mindset and unwavering commitment to excellence, she has built deep expertise in pharmaceutical forecasting, market opportunity assessment, and developing industry benchmarks. Her work is anchored in delivering actionable insights that empower clients to make informed strategic decisions.

    Mrinal’s core strength lies in translating complex quantitative datasets into meaningful business intelligence. Her analytical acumen is instrumental in shaping go-to-market (GTM) strategies and uncovering growth opportunities across the pharmaceutical and medical device sectors. As a trusted consultant, she consistently focuses on streamlining workflow processes and establishing best practices, thereby driving innovation and operational efficiency for her clients.

    • Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
    • PEST and SWOT Analysis
    • Market Size Value / Volume - Global, Regional, Country
    • Industry and Competitive Landscape
    • Excel Dataset

    Testimonials

    user

    I wish to appreciate your support and the professionalism you displayed in the course of attending to my request for information regarding to infectious disease IVD market in Nigeria. I appreciate your patience, your guidance, and the fact that you were willing to offer a discount, which eventually made it possible for us to close a deal. I look forward to engaging The Insight Partners in the future, all thanks to the impression you have created in me as a result of this first encounter.

    DR CHIJIOKE ONYIA, MANAGING DIRECTOR, PineCrest Healthcare Ltd.
    user

    The Insight Partners delivered insightful, well-structured market research with strong domain expertise. Their team was professional and responsive throughout. The user-friendly website made accessing industry reports seamless. We highly recommend them for reliable, high-quality research services

    Yukihiko Adachi CEO, Deep Blue, LLC.

    Reason to Buy

    • Informed Decision-Making
    • Understanding Market Dynamics
    • Competitive Analysis
    • Customer Insights
    • Market Forecasts
    • Risk Mitigation
    • Strategic Planning
    • Investment Justification
    • Identifying Emerging Markets
    • Enhancing Marketing Strategies
    • Boosting Operational Efficiency
    • Tracking Industry Innovations
    • Aligning with Regulatory Trends
    Your Key Concerns Addressed - Question & Answer
    Can I view a sample of the report before purchasing?

    Yes! We provide a free sample of the report, which includes Report Scope (Table of Contents), report structure, and selected insights to help you assess the value of the full report. Please click on the "Download Sample" button or contact us to receive your copy.

    Is analyst support included with the purchase?

    Absolutely — analyst assistance is part of the package. You can connect with our analyst post-purchase to clarify report insights, methodology or discuss how the findings apply to your business needs.

    What are the next steps once I place an order?

    Once your order is successfully placed, you will receive a confirmation email along with your invoice.

    • For published reports: You’ll receive access to the report within 4–6 working hours via a secured email sent to your email.
    • For upcoming reports: Your order will be recorded as a pre-booking. Our team will share the estimated release date and keep you informed of any updates. As soon as the report is published, it will be delivered to your registered email.

    Can the report be tailored to suit my specific needs?

    We offer customization options to align the report with your specific objectives. Whether you need deeper insights into a particular region, industry segment, competitor analysis, or data cut, our research team can tailor the report accordingly. Please share your requirements with us, and we’ll be happy to provide a customized proposal or scope.

    In what format is the report delivered?

    The report is available in either PDF format or as an Excel dataset, depending on the license you choose.

    The PDF version provides the full analysis and visuals in a ready-to-read format. The Excel dataset includes all underlying data tables for easy manipulation and further analysis.
    Please review the license options at checkout or contact us to confirm which formats are included with your purchase.

    How secure is the payment process on your platform?

    Our payment process is fully secure and PCI-DSS compliant.

    We use trusted and encrypted payment gateways to ensure that all transactions are protected with industry-standard SSL encryption. Your payment details are never stored on our servers and are handled securely by certified third-party processors.
    You can make your purchase with confidence, knowing your personal and financial information is safe with us.

    Do you provide special pricing for buying multiple reports?

    Yes, we do offer special pricing for bulk purchases.
    If you're interested in purchasing multiple reports, we’re happy to provide a customized bundle offer or volume-based discount tailored to your needs. Please contact our sales team with the list of reports you’re considering, and we’ll share a personalized quote.

    Can I connect with your team to discuss the report before buying?

    Yes, absolutely.
    Our team is available to help you make an informed decision. Whether you have questions about the report’s scope, methodology, customization options, or which license suits you best, we’re here to assist. Please reach out to us at sales@theinsightpartners.com, and one of our representatives will get in touch promptly.

    Will I get a billing invoice upon purchase?

    Yes, a billing invoice will be automatically generated and sent to your registered email upon successful completion of your purchase.
    If you need the invoice in a specific format or require additional details (such as company name, GST, or VAT information), feel free to contact us, and we’ll be happy to assist.

    Is there support available if I can’t access my report?

    Yes, certainly.
    If you encounter any difficulties accessing or receiving your report, our support team is ready to assist you. Simply reach out to us via email or live chat with your order information, and we’ll ensure the issue is resolved quickly so you can access your report without interruption.

    Our Clients
    The List of Companies

    1. Thermo Fisher Scientific Inc.
    2. Waters Corporation
    3. Agilent Technologies, Inc.
    4. Human Metabolome Technologies, Inc.
    5. Bruker Corporation
    6. Shimadzu Corporation
    7. PerkinElmer
    8. Metabolon, Inc.
    9. Leco Corporation
    10. Hitachi High-Technologies Corporation
    11. GL Sciences
    Sales Assistance
    US: +1-646-491-9876
    UK: +44-20-8125-4005
    Email: sales@theinsightpartners.com
    Chat with us
    DUNS Logo
    87-673-9708
    ISO Certified Logo
    ISO 9001:2015
    ISO Certified Logo